Wattle Health finalises supply agreement for China

Company News

by Rachael Jones

Wattle Health Australia ASX:WHA) has finalised the legally binding supply agreement with International Supplies and Distribution Company (ISDC) to supply their conventional cow infant formula for sale in general trade in China.

ISDC has guaranteed a total of over 5 million units of products over a 42- month period resulting in a revenue of around $100 million.

This agreement is an important milestone for Wattle in its China strategy as they expand their product portfolio.

WHA is actively selling baby food in China with a pipeline of products including fresh organic milk, organic senior nutritional products, sports nutrition and other organic powder based products.

Shares in Wattle Health Australia ASX:WHA) closed 0.61 per cent lower to 82 cents.
 

Rachael Jones

Finance News Network
Rachael comes to FNN after working for Fairfax Media covering international breaking news, including the global economy and politics. She joined FNN in February 2018. She has reported on Australia’s finance news for various organisations since 2000 and has also interviewed a number of key business players, including Bill Gates. Rachael has also worked across a number of countries, including the UK and the US.